Technology: Artificial intelligence, machine learning, and lab automation
Join us in this deep dive of a webinar, where industry leaders delve into the history and transformative potential of LLMs and automation in the lab.
Jonathan Wingfield, Principal Scientist at AstraZeneca: historical deployment of automation in pharma, its impact on early drug discovery, the necessary infrastructure, and the vision for the lab of the future
Abraham Heifets, CEO at Atomwise: the capabilities and limitations of AI in drug discovery, including ethical considerations and practical applications
Raminderpal Singh, AI Expert at HitchhikersAI: how small to mid-size biotechs can harness AI and data to enhance early drug discovery workflows
Janet Matsen and Helen Liu-Mayo, Product Manager and Software Engineer at Benchling: the diverse advancements of AI in drug discovery and receive actionable advice to prepare your organization for the future
